XENE
Xenon Pharmaceuticals Inc. · Healthcare
EVP, Drug Discovery James R. Empfield sold $1.6M of Xenon Pharmaceuticals Inc.
Sold$1,567,394
$30.63Price
51,168Shares
−84%Stake
What XENE did after the filing
- The stock from Tue, Mar 8 close, $30.45
- +11.1%
- S&P 500, same days
- +7.2%
Measured over 30 trading days, to the Apr 20 close.
Traded Fri, Mar 4. Filed Tue, Mar 8, 2:32 PM ET, during the session. Returns use the Mar 8 close and the Apr 20 close. Not investment advice.